PROXY STATEMENT

Company

Inmune Bio, Inc.

Filed

May 29, 2024

Period of Report

July 19, 2024

Accession Number

0001213900-24-047456

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →